Biomics Biopharma (ASX:BBM) Scaled Net Operating Assets : (As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Biomics Biopharma's operating assets for the quarter that ended in . 20 was A$ Mil. Biomics Biopharma's operating liabilities for the quarter that ended in . 20 was A$ Mil. Biomics Biopharma's Total Assets for the quarter that ended in . 20 was A$ Mil. Therefore, Biomics Biopharma's scaled net operating assets (SNOA) for the quarter that ended in . 20 was .

Biomics Biopharma Scaled Net Operating Assets Historical Data

The historical data trend for Biomics Biopharma's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Scaled Net Operating Assets Chart

Biomics Biopharma Annual Data

Trend

Scaled Net Operating Assets

Biomics Biopharma Semi-Annual Data

Scaled Net Operating Assets

Competitive Comparison of Biomics Biopharma's Scaled Net Operating Assets

For the Biotechnology subindustry, Biomics Biopharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomics Biopharma's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomics Biopharma's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Biomics Biopharma's Scaled Net Operating Assets falls into.

Biomics Biopharma Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Biomics Biopharma's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in . 20 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: . 20 )
=	(Operating Assets (A: . 20 )	-	Operating Liabilities (A: . 20 ))	/	Total Assets (A: . 20 )
=	(	-	)	/
=

where

	Operating Assets		(A: . 20 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=		-
=

	Operating Liabilities		(A: . 20 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=		-		-
=

Biomics Biopharma's Scaled Net Operating Assets (SNOA) for the quarter that ended in . 20 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: . 20 )
=	(Operating Assets (Q: . 20 )	-	Operating Liabilities (Q: . 20 ))	/	Total Assets (Q: . 20 )
=	(	-	)	/
=

where

	Operating Assets		(Q: . 20 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=		-
=

	Operating Liabilities		(Q: . 20 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=		-		-
=

Biomics Biopharma Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomics Biopharma (ASX:BBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Scaled Net Operating Assets

Comparable Companies

ASX:G88 ASX:ELS ASX:BHD ASX:IBX ASX:ZEN ASX:OLI ASX:KPG ASX:CAN ASX:MPW ASX:CQG ASX:OCA

Traded in Other Exchanges

N/A

Address

1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000

Website

http://www.biomics.com

Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines